2019
DOI: 10.3390/ijms20215386
|View full text |Cite
|
Sign up to set email alerts
|

Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine

Abstract: Mesenchymal stem cells (MSC) have piqued worldwide interest for their extensive potential to treat a large array of clinical indications, their unique and controversial immunogenic and immune modulatory properties allowing ample discussions and debates for their possible applications. Emerging data demonstrating that the interaction of biomaterials and physical cues with MSC can guide their differentiation into specific cell lineages also provide new interesting insights for further MSC manipulation in differe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
27
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 25 publications
(27 citation statements)
references
References 226 publications
(245 reference statements)
0
27
0
Order By: Relevance
“…Moreover, classical osteogenesis assays are time-consuming, with both in vitro and in vivo functional assays requiring several weeks of time to complete. In addition, all these assays are performed with primary cells whether it be osteoblasts, pre-osteoblasts, or mesenchymal stem cells (MSCs) which are the progenitors of osteogenic cells ( Zheng et al, 2018 , 2019 ; Abdelrazik et al, 2019 ; Lavrentieva et al, 2020 ), all which require primary isolation and can lose osteogenic capacity when senescent after prolonged in vitro passaging ( Moerman et al, 2004 ; Ho et al, 2013 ; Liu et al, 2020 ). Thus, development of a robust and rapid screening platform for selection of phytoestrogens and other plant-based compounds with strong osteogenic agonistic properties is sorely needed.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, classical osteogenesis assays are time-consuming, with both in vitro and in vivo functional assays requiring several weeks of time to complete. In addition, all these assays are performed with primary cells whether it be osteoblasts, pre-osteoblasts, or mesenchymal stem cells (MSCs) which are the progenitors of osteogenic cells ( Zheng et al, 2018 , 2019 ; Abdelrazik et al, 2019 ; Lavrentieva et al, 2020 ), all which require primary isolation and can lose osteogenic capacity when senescent after prolonged in vitro passaging ( Moerman et al, 2004 ; Ho et al, 2013 ; Liu et al, 2020 ). Thus, development of a robust and rapid screening platform for selection of phytoestrogens and other plant-based compounds with strong osteogenic agonistic properties is sorely needed.…”
Section: Introductionmentioning
confidence: 99%
“…Stem cells can differentiate into many types of cells and they can substitute for injured tissues and fulfill the repair process through the paracrine mechanism at the injury location. Stem cells have been used successfully in the treatment of hematological malignancies, graft-versus-host disease, acute thrombocytopenia, and autoimmune diseases in several experimental in vivo studies [4,5]. However, large-scale production,…”
Section: Introductionmentioning
confidence: 99%
“…Specific features of MSCs rely on their self-renewal ability, low immunogenicity, and the ability to migrate, proliferate, and differentiate in different cell types [ 9 , 10 ]. Notably, the biological activities associated with MSCs migration and proliferation are of particular importance because they are involved in tissue regeneration.…”
Section: Introductionmentioning
confidence: 99%